Search Results - "Pérez‐Galindo, P."

Harvest intensity of aromatic shrubs vs. soil erosion: An equilibrium for sustainable agriculture (SE Spain) by DURÁN ZUAZO, V.H, RODRIGUEZ PLEGUEZUELO, C.R, FRANCIA MARTINEZ, J.R, CÁRCELES RODRIGUEZ, B, MARTINEZ RAYA, A, PÉREZ GALINDO, P

“…In the Mediterranean Europe, where rainfall is scarce and irregular but often of high intensity, wild shrubs protect the soil against erosivity of raindrops…”
Get full text

Tacrolimus induces short‐term but not long‐term clinical response in inflammatory bowel disease by Rodríguez‐Lago, Iago, Castro‐Poceiro, Jesús, Fernández‐Clotet, Agnès, Mesonero, Francisco, López‐Sanromán, Antonio, López‐García, Alicia, Márquez, Lucía, Clos‐Parals, Ariadna, Cañete, Fiorella, Vicuña, Miren, Nantes, Óscar, Merino, Olga, Matallana, Virginia, Gordillo, Jordi, Elorza, Ainara, Vicente, Raquel, Casanova, María José, Ferreiro‐Iglesias, Rocío, Pérez‐Galindo, Pablo, Benítez, José Manuel, Taxonera, Carlos, García, María José, Martín, Eduardo, Aguirre, Urko, Gisbert, Javier P., Rodríguez‐Lago, I., Elorza, A., Castro‐Poceiro, J., Fernández‐Clotet, A., Mesonero, F., López‐Sanromán, A., López‐García, A., Márquez, L., Clos‐Parals, A., Cañete, F., Vicuña, M., Nantes, O., Merino, O., Matallana, V., Gordillo, J., Vicente, R., Casanova, M. J., Gisbert, J. P., Ferreiro‐Iglesias, R., Pérez‐Galindo, P., Manuel Benítez, J., Taxonera, C., García, M. J., Martín, E., Aguirre, U., Calafat, M., Muñoz, F., Miquel‐Cusachs, J. O., Sáinz, E.

“…Summary Background Tacrolimus is a calcineurin inhibitor commonly used for prophylaxis of rejection in renal and liver transplantation. There are limited but…”
Get full text

P829 Clostridioides difficile infection in patients using vedolizumab and antiTNF: incidence and consequences (CDIFVEDO study of GETECCU) by Gonzalez Vivo, M, Font Ordeig, G, López Romero-Salazar, F, Camblor García, C, Suarez Ferrer, C, Melcarne, L, de la Serna Gamboa, A, Gómez Otero, M, Hernández Camba, A, Rubín de Célix, C, Irabien, M, Caballero-Mateos, A M, García, M J, Pérez Santamaria, C, Vázquez García, P, Castro Poceiro, J, Moralejo Lozano, O, Rodríguez Grau, M C, Pérez Galindo, P, Iglesias Doallo, A, Jiménez García, N, Ruiz-Rodríguez, J, Teller Martin, M, Riera Roig, J, Marquez-Mosquera, L, Benítez, J M, Zabana, Y, Gutiérrez, A

“…Abstract Background Clostridioides difficile infection (CDI) is a frequent cause of flares in inflammatory bowel disease (IBD) and it is related to higher risk…”
Get full text

P211 Impact of celiac disease on the outcome of Inflammatory Bowel Disease by Alonso, I, Ramos, L, Hernández-Camba, A, Yagüe-Caballero, C, Vicente Lidón, R, Taxonera, C, García-Brenes, M A, Gisbert, J P, Chaparro, M, Madero Velázquez, L, Carrillo-Palau, M, Arranz Hernández, L, Castro Senosiain, B, García de la Filia Molina, I, Rojas-Feria, M, López Romero-Salazar, F, Bastón-Rey, I, Sánchez-Azofra, M, Riestra, S, Pérez-Galindo, P, Ortega Moya, S P, Brunet-Mas, E, Sanz Segura, P, Caballero-Mateos, A M, Calafat, M, Botella Mateu, B, Manceñido Marcos, N, Rodríguez-Lago, I, Suárez-Ferrer, C, Gutiérrez Casbas, A

“…Abstract Background Inflammatory bowel disease (IBD) and celiac disease (CeD) are digestive disorders that share common genetic, immunological, and…”
Get full text

P335 Impact of cancer therapy on the course of Inflammatory Bowel Disease (ONCOEII study of GETECCU) by Pérez Galindo, P, Benítez, J M, Rubín de Célix, C, Mesonero, F, Castaño García, A, García, M J, Vicuña, M, Bernal, L, Bertoletti, F, Ramírez Castro, C, Sánchez-Azofra, M, Sánchez-Delgado, L, Ponferrada, Á, Tejido Sandoval, C, Capilla, M, Laredo de la Torre, V, Diz-Lois, M T, Dueñas Sadornil, C, García-Morales, N, González-Vivo, M, López-Cauce, B, Melcarne, L, Calviño-Suárez, C, Lastiri González, E, Ramírez de la Piscina, P, Gisbert, J P, Pérez Martínez, I, Castro, B, Cousillas, A, Mañosa, M, Carpio, D, Barreiro-de Acosta, M

“…Abstract Background Cancer in inflammatory bowel disease (IBD) patients is increasing mainly due to the aging of patients. There are few data regarding the…”
Get full text

P327 Characteristics of esophago-gastro-duodenal Crohn’s disease in the biologic era: a nationwide study of the Young GETECCU Group by López García, A, Benítez, J M, Maroto-Martín, C, Fernández-Prada, S J, Marquina, V, Rodríguez, G E, Mesonero, F, Lucendo, A J, Flórez-Díez, P, Casanova, M J, García-Morales, N, Miranda, J, Vicuña, M, Font, G, Suárez-Ferrer, C, Bernal, L, Peries, L, Mínguez, A, Tejedor, J, Pérez-Galindo, P, Elosua, A, Lastiri, E A, Brunet, E, Llaó, J, Rodríguez-Lago, I, Ferreiro-Iglesias, R, López, L, González, I, Ortega, S P, Monsalve, S, Márquez-Mosquera, L, González-Vivó, M, Murciano, F, Zabana, Y, Barreiro-de Acosta, M

“…Abstract Background There is scarce information about Crohn’s disease (CD) affecting oesophagus, stomach and duodenum. The aim of the study was to describe…”
Get full text

P276 Influence of vedolizumab on extraintestinal manifestations in Inflammatory Bowel Disease: a nationwide multicenter study of the GETECCU Eneida registry by Pérez Galindo, P, Gisbert, J P, Carrillo-Palau, M, Bertoletti, F, González-Vivó, M, Ferrer, J A, Pajares, R, Merino, O, Castaño, A, Chaparro, M, Calvo, M, Barreiro-de-Acosta, M, Rodríguez, A, Lorente, R H, Algaba, A, Riado, D, Vela, M, De-la-Maza, S, Llaó, J, Vega, P, Utrilla, A, Almela, P, Carpio, D

“…Abstract Background Evidence regarding vedolizumab (VDZ) influence on extraintestinal manifestations (EIMs) in inflammatory bowel disease patients (IBD) is…”
Get full text

DOP04 Inflammatory Bowel Disease (IBD) and Solid Organ Transplantation. Natural history of pre-existing and de novo IBD patients. (EITOS study of GETECCU) by Bastón Rey, I, Calvino Suárez, C, Luque, A M, Caballol, B, Soutullo, C, Bravo, A, Castaño, A, Gros, B, Bernal, L, Diz Lois, M T, Alonso Galán, H, Cañete, F, Castro, B, Pérez Galindo, P, González Muñoza, C, El Hajra, I, Martínez Montiel, P, Alonso Abreu, I, Mesonero, F, González Vivo, M, Peries, L, Martín Arranz, E, Abril, C, Marín Jiménez, I, Baltar, R, Vicuna, M, Moreno, N, Brunet, E, Rubín de Célix, C, Fajardo, I, Cruz, N, Rojas Feria, M, Fernández Clotet, A, Gimeno, M, Zabana, Y, Suárez Ferrer, C, Rodríguez Lago, I, Barreiro de Acosta, M

“…Abstract Background Limited data is available of the outcome of inflammatory bowel disease (IBD) in patients with solid organ transplantation (SOT). The aim of…”
Get full text

P349 Safety of Inflammatory Bowel Disease treatments in patients with Solid Organ Transplantation (EITOS study of GETECCU) by Bastón Rey, I, Calvino Suárez, C, Luque, A M, Caballol, B, Soutullo, C, Bravo, A, Castaño, A, Gros, B, Hurtado, A, Vázquez Rey, T, Alonso Galán, H, Cañete, F, Castro, B, Pérez Galindo, P, González Muñoza, C, El Hajra, I, Martínez Montiel, P, Alonso Abreu, I, Mesonero, F, González Vivo, M, Peries, L, Martín Arranz, E, Abril, C, Marín Jiménez, I, Baltar, R, Vicuña, M, Moreno, N, Brunet, E, Rodríguez Lago, I, Rubín de Célix, C, Fajardo, I, Cruz, N, Rojas Feria, M, Fernández Clotet, A, Gimeno, M, Zabana, Y, Suárez Ferrer, C, Barreiro de Acosta, M

“…Abstract Background Inflammatory bowel disease (IBD) in patients with solid organ transplantation (SOT) is associated with a greater complexity in their…”
Get full text

P550 Long-term effectiveness of anti-TNF agents in symptomatic stricturing Crohn’s disease by Rodríguez-Lago, I, Del Hoyo, J, Casanova, M J, Fernández-Clotet, A, García, M J, Ferreiro-Iglesias, R, Piqueras, M, Suárez, C, López-García, A, Arroyo, M, Sierra, M, Delgado-Guillena, P, Guerra, I, Merino, O, Arranz, L, Llaó, J, Plaza, R, Molina, G, Torres, P, Pérez-Galindo, P, Herrera-deGuise, C, Armesto, E, Mesonero, F, Aguirre, U, Gisbert, J P

“…Abstract Background Approximately one half of the patients with Crohn’s disease (CD) develop intestinal strictures during their lifetime. The effectiveness of…”
Get full text

P223 Efficacy and safety of tacrolimus in Crohn’s disease: a nationwide, multi-centric study from GETECCU by Rodriguez-Lago, I, Castro-Poceiro, J, Fernández-Clotet, A, Mesonero, F, López-Sanromán, A, López-García, A, Márquez, L, Clos-Parals, A, Cañete, F, Vicuña, M, Nantes, Ó, Merino, O, Matallana Royo, V, Gordillo, J, Elorza, A, Sanz, P, Casanova, M J, Ferreiro-Iglesias, R, Pérez-Galindo, P, Benítez, J M, Taxonera, C, García García, M J, Martín Arranz, E, Calafat, M, Martín-Cardona, A, Muñoz Núñez, F, Miquel-Cusachs, J O, Sáinz Arnau, E, Gisbert, J P

“…Abstract Background Crohn's disease (CD) is chronic inflammatory disease of the gastrointestinal tract. Tacrolimus (TCR) is a calcineurin inhibitor drug…”
Get full text

DOP44 Efficacy and safety of tacrolimus in ulcerative colitis: a nationwide, multi-centre study from GETECCU by Rodriguez-Lago, I, Castro-Poceiro, J, Fernández-Clotet, A, Mesonero, F, López-Sanromán, A, López-García, A, Márquez, L, Clos-Parals, A, Cañete, F, Vicuña, M, Nantes, Ó, Merino, O, Matallana Royo, V, Gordillo, J, Elorza, A, Vicente, R, Casanova, M J, Ferreiro-Iglesias, R, Pérez-Galindo, P, Benítez, J M, Taxonera, C, García García, M J, Martín Arranz, E, Calafat, M, Martín-Cardona, A, Muñoz Núñez, F, Miquel-Cusachs, J O, Sáinz Arnau, E, Gisbert, J P

“…Abstract Background Ulcerative colitis (UC) is a chronic disorder of the gut. Tacrolimus (TCR) is a calcineurin inhibitor drug commonly used for prophylaxis of…”
Get full text

P523 Effectiveness of biological treatments for inflammatory bowel disease in the elderly patients by Suarez Ferrer, C J, Mesonero, F, Caballol, B, Ballester, M P, Baston Rey, I, Castaño Garcia, A, Miranda Bautista, J, Saiz Chumillas, R, Benitez, J M, Sanchez Delgado, L, Lopez-Garcia, A, Rubin de Celix, C, Martin-Arranz, M D, Lopez Sanroman, A, Fernandez-Clotet, A, Merino Murgui, V, Calviño Suarez, C, Florez, P, Lobato Matilla, M E, Sicilia, B, Soto Escribano, P, Maroto Martin, C, Alonso Abreu, I, Melcarne, L, Elena, P G, Iyo, E, Elosua Gonzalez, A, Saiz, E, Hernandez Villalba, L, Perez Galindo, P, Torrealba Medina, L, Monsalve Alonso, S, Olmos Jerez, J A, Dueñas Sadornil, C, Barreiro-De Acosta, M

“…Abstract Background Biological treatments used for the treatment of inflammatory bowel disease (IBD) have demonstrated their efficacy and safety, although…”
Get full text

P338 effectiveness and safety of biological therapies in elderly inflammatory bowel diseases patients results from a multi center study of Geteccu by Suarez Ferrer, C J, Mesonero, F, Caballol, B, Saiz Chumillas, R, Bastón-Rey, I, Rubin de Celix, C, Melcarne, L, Caballero Mateos, A, Calafat, M, Alonso Galan, H, Vega Villaamil, P, Castro Senosiain, B, Rodriguez Diaz, C Y, Plaza Santos, R, Marques Cami, M, Rodriguez Grau, M C, Ramirez, F, Lopez-García, A, Gomez Pastrana, B, Gonzalez Partida, I, Botella Mateu, B, Cuevas del Campo, L, Gonzalez Peña, E, Iyo, E, Elosua Gonzalez, A, Sainz, E, Hernandez, L, Perez Galindo, P, Rueda Garcia, J L, Martin-Arranz, M D, Lopez Sanroman, A, Fernandez-Clotet, A, Sicilia, B, Calviño Suárez, C, Mañosa Ciria, M, Barreiro-De Acosta, M

“…Abstract Background Biological drugs are being increasingly used for the treatment of inflammatory bowel diseases (IBD) in elderly patients. Despite the…”
Get full text

Origanum bastetanum Soc. cultivated specimens: characterization of its essential oil by Perez-Galindo, P, Martinez-Raya, A, Francia, J.R, Jimenez, J, Navarro, C

“…Through a combination of GC and GC/MS, we studied the Origanum bastetanum Soc. essential oil obtained from the aerial parts submitted to three different…”
Get full text